Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11433013
Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof
granted -
US 11435366
Noninvasive method to quantify kidney function and functional decline
granted -
US 11434304
Anti-CD38 antibodies
granted -
US 11434485
Synthetic transfer RNA with extended anticodon loop
granted -
US 11434293
Anti TRBC1 antigen binding domains
granted -
US 11434487
Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
granted -
US 11434272
Anti-human papillomavirus 16 E7 T cell receptors
granted -
US 11433091
Methods and compositions for administration of iron
granted -
US 11435349
CD127 expression inversely correlates with FoxP3 and suppressive function of CD4+ Tregs
granted -
US 11433025
Oil foamable carriers and formulations
granted -
US 11433038
High concentration medicant solutions for treating neurological disorders
granted -
US 11434505
Universal donor cells
granted -
US 11433143
Nano-enabled immunotherapy in cancer
granted -
CN 115003329
Parapoxvirus for conditioning and treating coronavirus infections
granted -
US 11427571
Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
granted -
US 11426461
Methods for preventing dengue and hepatitis A
granted -
US 11426366
Compositions and methods for treating motor disorders
granted -
US 11426418
Injectable long-acting semi-solid gel formulations
granted -
US 11427822
Modified double-stranded RNA agents
granted -
US 11427820
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
granted -
US 11427838
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
granted -
US 11426420
Inhibitors of short-chain dehydrogenase activity for treating coronary disorders
granted -
US 11427540
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 11426446
Stable aqueous formulations of aflibercept
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.